Physician

Yvan Maque Acosta, M.D.

According to 2025 Medicare claims, Yvan Acosta, M.D. (NPI: 1306252648) practices internal medicine in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is INFUSION SOLUTIONS OF DELAWARE (NPI: 1073614103; TIN: 010863383) and primary practice location at 19904-3309.

Acosta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 603 traditional Medicare patients, billed 171,037 HCPCS/CPT codes, and received $2,615,425 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,321 prescription claims across 260 beneficiaries totaling $1,463,294 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 69 records totaling $1,575. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,763 to $1,463,294. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2022 Medicare payment: $948,185 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,990,147 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,615,425 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202253066,312$948,185
2023571136,983$1,990,147
2024603171,037$2,615,425

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$732K$1.5M2017 Drug cost: $12,763 (USD; Tot_Drug_Cst)2018 Drug cost: $16,263 (USD; Tot_Drug_Cst)2019 Drug cost: $111,480 (USD; Tot_Drug_Cst)2020 Drug cost: $360,359 (USD; Tot_Drug_Cst)2021 Drug cost: $291,704 (USD; Tot_Drug_Cst)2022 Drug cost: $219,204 (USD; Tot_Drug_Cst)2023 Drug cost: $974,601 (USD; Tot_Drug_Cst)2024 Drug cost: $1,463,294 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201721145$12,763
201848392$16,263
201971495$111,480
202099412$360,359
202143153$291,704
2022192716$219,204
20232381,177$974,601
20242601,321$1,463,294

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more120120$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more253525$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more243283$62
J0897Injection, denosumab, 1 mg24224,660$21
96372Injection of drug or substance under skin or into muscle259450$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab561,960$480,751
Enbrel SureclickEtanercept17728$185,714
RinvoqUpadacitinib14840$176,040
Cosentyx Sensoready PenSecukinumab14448$143,032
TymlosAbaloparatide231,230$110,804

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.69$1,575Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Yvan Maque Acosta, M.D.?

Tedicare shows public-source Medicare data for Yvan Maque Acosta, M.D. (NPI 1306252648), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yvan Maque Acosta, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yvan Maque Acosta, M.D.?

Yvan Maque Acosta, M.D. is linked to INFUSION SOLUTIONS OF DELAWARE (billing NPI 1073614103) in the available physician profile data.

Does Yvan Maque Acosta, M.D. have Open Payments data?

Yvan Maque Acosta, M.D. has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.